Charles River Laboratories International, Inc. (CRL) reported fourth-quarter 2023 adjusted earnings per share (EPS) of $2.46, which reflected a 17.4% decrease year over year. However, the metric surpassed the Zacks Consensus Estimate by 2.9%.On a GAAP basis, earnings declined 0.8% year over year to $3.62 per share. The year-over-year decrease in GAAP earnings was primarily due to lower revenues and operating income.For the full year, adjusted EPS was $10.67 per share, down 4% from the year-ago period’s leve ...